RN

13.9k total citations · 7 hit papers
67 papers, 10.3k citations indexed

About

RN is a scholar working on Social Psychology, Economics and Econometrics and Pharmacology. According to data from OpenAlex, RN has authored 67 papers receiving a total of 10.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Social Psychology, 21 papers in Economics and Econometrics and 19 papers in Pharmacology. Recurrent topics in RN's work include Mental Health Treatment and Access (22 papers), Treatment of Major Depression (17 papers) and Health Systems, Economic Evaluations, Quality of Life (15 papers). RN is often cited by papers focused on Mental Health Treatment and Access (22 papers), Treatment of Major Depression (17 papers) and Health Systems, Economic Evaluations, Quality of Life (15 papers). RN collaborates with scholars based in United States, Canada and Germany. RN's co-authors include Ronald C. Kessler, Howard G. Birnbaum, Andrée-Anne Fournier, Hagop S. Akiskal, Kathleen R. Merikangas, Crystal Pike, Robert M. A. Hirschfeld, Maria Petukhova, Jules Angst and Stephanie A. Leong and has published in prestigious journals such as PLoS ONE, American Journal of Psychiatry and Diabetes Care.

In The Last Decade

RN

65 papers receiving 9.7k citations

Hit Papers

Lifetime and 12-Month Prevalence of Bipolar Spectrum Diso... 1999 2026 2008 2017 2007 2015 2003 1999 2006 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
RN United States 36 3.8k 2.6k 2.0k 1.9k 1.9k 67 10.3k
Hannie C. Comijs Netherlands 61 4.0k 1.1× 2.5k 1.0× 1.2k 0.6× 1.5k 0.8× 918 0.5× 292 11.8k
Cornelius Katona United Kingdom 65 5.7k 1.5× 3.1k 1.2× 1.3k 0.7× 3.2k 1.7× 2.4k 1.3× 334 14.0k
Ira R. Katz United States 59 5.0k 1.3× 2.7k 1.0× 1.7k 0.9× 2.1k 1.1× 1.9k 1.0× 220 12.4k
José Luís Ayuso‐Mateos Spain 62 4.8k 1.3× 4.3k 1.7× 3.1k 1.6× 2.7k 1.4× 1.1k 0.6× 321 15.7k
Rachel Churchill United Kingdom 47 2.0k 0.5× 3.7k 1.4× 1.1k 0.6× 1.5k 0.8× 1.7k 0.9× 158 10.2k
Paul Stang United States 56 3.0k 0.8× 2.3k 0.9× 1.6k 0.8× 2.0k 1.1× 1.6k 0.8× 137 12.7k
Chee H. Ng Australia 55 3.8k 1.0× 5.8k 2.3× 2.1k 1.1× 2.0k 1.1× 1.2k 0.6× 454 14.7k
Richard Morriss United Kingdom 55 5.3k 1.4× 3.1k 1.2× 1.4k 0.7× 1.9k 1.0× 1.6k 0.9× 270 10.3k
Aart H. Schene Netherlands 67 4.6k 1.2× 4.5k 1.8× 2.9k 1.5× 2.3k 1.2× 2.1k 1.1× 332 15.9k
W. van Tilburg Netherlands 54 3.3k 0.9× 3.1k 1.2× 1.8k 0.9× 2.4k 1.2× 747 0.4× 145 11.3k

Countries citing papers authored by RN

Since Specialization
Citations

This map shows the geographic impact of RN's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RN with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RN more than expected).

Fields of papers citing papers by RN

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by RN. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RN. The network helps show where RN may publish in the future.

Co-authorship network of co-authors of RN

This figure shows the co-authorship network connecting the top 25 collaborators of RN. A scholar is included among the top collaborators of RN based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with RN. RN is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Corey‐Lisle, Patricia K., et al.. (2025). Economic Impact of Olanzapine Plus Fluoxetine Combination Therapy Among Patients Treated for Depression: A Pilot Study. Psychopharmacology Bulletin. 37(3). 90–98.
2.
RN, et al.. (2023). Impact of living with an adult with depressive symptoms among households in the United States. Journal of Affective Disorders. 349. 107–115. 3 indexed citations
3.
RN, et al.. (2021). Introduction to the Special Issue of PharmacoEconomics on Major Depressive Disorders. PharmacoEconomics. 39(6). 617–617. 2 indexed citations
4.
Thesmar, David, et al.. (2019). Combining the Power of Artificial Intelligence with the Richness of Healthcare Claims Data: Opportunities and Challenges. PharmacoEconomics. 37(6). 745–752. 55 indexed citations
5.
Birnbaum, Howard G., Rym Ben-Hamadi, David Kelley, et al.. (2010). Assessing the Relationship Between Compliance With Antidepressant Therapy and Employer Costs Among Employees in the United States. Journal of Occupational and Environmental Medicine. 52(2). 115–124. 11 indexed citations
6.
Birnbaum, Howard G., RN, Jackson Tang, et al.. (2009). Antidepressant treatment patterns and costs among US employees. Journal of Medical Economics. 12(1). 36–45. 3 indexed citations
7.
Birnbaum, Howard G., et al.. (2009). Determinants of Direct Cost Differences among US Employees with Major Depressive Disorders Using Antidepressants. PharmacoEconomics. 27(6). 507–517. 25 indexed citations
9.
Duh, Mei Sheng, Kevin E. Cahill, Pierre Emmanuel Paradis, Pierre Y. Crémieux, & RN. (2009). The economic implications of generic substitution of antiepileptic drugs: a review of recent evidence. Expert Opinion on Pharmacotherapy. 10(14). 2317–2328. 20 indexed citations
10.
Birnbaum, Howard G., Alan G. White, Jennifer L. Reynolds, et al.. (2006). Estimated Costs of Prescription Opioid Analgesic Abuse in the United States in 2001. Clinical Journal of Pain. 22(8). 667–676. 114 indexed citations
11.
Kessler, Ronald C., Hagop S. Akiskal, Minnie Ames, et al.. (2006). Prevalence and Effects of Mood Disorders on Work Performance in a Nationally Representative Sample of U.S. Workers. American Journal of Psychiatry. 163(9). 1561–1568. 621 indexed citations breakdown →
12.
Duh, Mei Sheng, et al.. (2006). Impact and treatment of anemia in the elderly: clinical, epidemiological and economic perspectives. Expert Review of Pharmacoeconomics & Outcomes Research. 6(5). 577–590. 6 indexed citations
13.
Kessler, Ronald C., Lenard A. Adler, Minnie Ames, et al.. (2005). The Prevalence and Effects of Adult Attention Deficit/Hyperactivity Disorder on Work Performance in a Nationally Representative Sample of Workers. Journal of Occupational and Environmental Medicine. 47(6). 565–572. 257 indexed citations
14.
RN, Patricia K. Corey‐Lisle, Howard G. Birnbaum, Maryna Marynchenko, & Ami Claxton. (2004). Economic Implications of Treatment-Resistant Depression Among Employees. PharmacoEconomics. 22(6). 363–373. 95 indexed citations
15.
Birnbaum, Howard G., et al.. (2003). Economic Consequences of Not Recognizing Bipolar Disorder Patients. The Journal of Clinical Psychiatry. 64(10). 1201–1209. 82 indexed citations
16.
Swensen, Andrine R., Howard G. Birnbaum, Kristina Secnik, et al.. (2003). Attention-Deficit/Hyperactivity Disorder: Increased Costs for Patients and Their Families. Journal of the American Academy of Child & Adolescent Psychiatry. 42(12). 1415–1423. 148 indexed citations
17.
Kessler, Ronald C., RN, Kristin D. Mickelson, Laurie Meneades, & Philip S. Wang. (2001). The Effects of Chronic Medical Conditions on Work Loss and Work Cutback. Journal of Occupational and Environmental Medicine. 43(3). 218–225. 383 indexed citations
18.
RN, et al.. (1999). Pharmacoeconomics and Health Policy. PharmacoEconomics. 16(5). 425–432. 26 indexed citations
19.
RN, Ronald C. Kessler, Stan N. Finkelstein, et al.. (1999). The Economic Burden of Anxiety Disorders in the 1990s. The Journal of Clinical Psychiatry. 60(7). 427–435. 908 indexed citations breakdown →
20.
RN, Stan N. Finkelstein, & Ernst R. Berndt. (1995). Economic Consequences of Illness in the Workplace. 36(4). 26–38. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026